{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:58Z","timestamp":1791919078678,"version":"4.3.4"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,15]]},"DOI":"10.1093\/hmg\/ddu445","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T05:32:06Z","timestamp":1409290326000},"page":"314-329","source":"Crossref","is-referenced-by-count":34,"title":["Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors"],"prefix":"10.1093","volume":"24","author":[{"given":"Madoka","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Tohnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Ikenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"key\n\t\t\t\t20170522171324_DDU445C1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrg2748","article-title":"Repeat expansion disease: progress and puzzles in disease pathogenesis","volume":"11","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"key\n\t\t\t\t20170522171324_DDU445C2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait","volume":"18","year":"1968","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522171324_DDU445C3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/brain\/112.1.209","article-title":"X-linked recessive bulbospinal neuronopathy. A clinicopathological study","volume":"112","year":"1989","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170522171324_DDU445C4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","article-title":"Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)","volume":"99","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","year":"2002","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522171324_DDU445C6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/nm.2932","article-title":"Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract","volume":"18","year":"2012","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522171324_DDU445C7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","article-title":"Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy","volume":"67","year":"2010","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522171324_DDU445C8","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.3032-06.2006","article-title":"Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration","volume":"26","year":"2006","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","article-title":"Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females","volume":"264","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C10","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awp258","article-title":"Clinical features of spinal and bulbar muscular atrophy","volume":"132","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170522171324_DDU445C11","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/brain\/aws170","article-title":"Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy","volume":"135","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170522171324_DDU445C12","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","article-title":"Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"24","year":"2004","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","article-title":"Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy","volume":"63","year":"2009","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522171324_DDU445C14","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773.","article-title":"Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model","volume":"116","year":"2006","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522171324_DDU445C15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","article-title":"Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy","volume":"7","year":"2014","journal-title":"Cell Rep."},{"key":"key\n\t\t\t\t20170522171324_DDU445C16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","year":"2014","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522171324_DDU445C17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/hmg\/ddn310","article-title":"Mitochondrial abnormalities in spinal and bulbar muscular atrophy","volume":"18","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522171324_DDU445C18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0361-9230(01)00583-4","article-title":"Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy","volume":"56","year":"2001","journal-title":"Brain Res. Bull."},{"key":"key\n\t\t\t\t20170522171324_DDU445C19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522171324_DDU445C20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPAR\u03b3","volume":"77","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"key\n\t\t\t\t20170522171324_DDU445C21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2004.12.015","article-title":"Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis","volume":"161","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C22","first-page":"63","article-title":"The PPAR-\u03b3 agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function","volume":"9","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"key\n\t\t\t\t20170522171324_DDU445C23","doi-asserted-by":"crossref","first-page":"e55080","DOI":"10.1371\/journal.pone.0055080","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522171324_DDU445C24","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease","volume":"283","year":"2008","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522171324_DDU445C25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mus.23413","article-title":"Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy","volume":"46","year":"2012","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522171324_DDU445C26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroscience.2010.12.029","article-title":"Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-\u03baB signaling pathway","volume":"176","year":"2011","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170522171324_DDU445C27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","year":"2004","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170522171324_DDU445C28","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","article-title":"Mechanisms underlying the rapid peroxisome proliferator-activated receptor-\u03b3-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease","volume":"32","year":"2012","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/CIRCRESAHA.110.216523","article-title":"Control of macrophage activation and function by PPARs","volume":"106","year":"2010","journal-title":"Circ. Res."},{"key":"key\n\t\t\t\t20170522171324_DDU445C30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","year":"2007","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170522171324_DDU445C31","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522171324_DDU445C32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mus.20489","article-title":"Mitochondrial dysfunction and amyotrophic lateral sclerosis","volume":"33","year":"2006","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522171324_DDU445C33","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"key\n\t\t\t\t20170522171324_DDU445C34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","year":"2002","journal-title":"Nat. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nrg1690","article-title":"Therapeutics development for triplet repeat expansion diseases","volume":"6","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"key\n\t\t\t\t20170522171324_DDU445C36","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/NEN.0b013e318275df4b","article-title":"Decreased mRNA expression of PGC-1\u03b1 and PGC-1\u03b1-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS","volume":"71","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C37","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddt202","article-title":"PGC-1\u03b1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis","volume":"22","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522171324_DDU445C38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","year":"2005","journal-title":"Exp. Neurol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C39","doi-asserted-by":"crossref","first-page":"418765","DOI":"10.1155\/2008\/418765","article-title":"Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and huntington's disease","volume":"2008","year":"2008","journal-title":"PPAR Res."},{"key":"key\n\t\t\t\t20170522171324_DDU445C40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","article-title":"Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-upsilon (PPARUpsilon) in Huntington's disease","volume":"96","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"key\n\t\t\t\t20170522171324_DDU445C41","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170522171324_DDU445C42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20170522171324_DDU445C43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1096\/fj.01-0793com","article-title":"Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size","volume":"16","year":"2002","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170522171324_DDU445C44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cardiores.2003.12.027","article-title":"Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion","volume":"62","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"key\n\t\t\t\t20170522171324_DDU445C45","doi-asserted-by":"crossref","first-page":"658520","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","year":"2008","journal-title":"PPAR Res."},{"key":"key\n\t\t\t\t20170522171324_DDU445C46","doi-asserted-by":"crossref","first-page":"e37885","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522171324_DDU445C47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents","volume":"166","year":"2005","journal-title":"Exp. Brain Res."},{"key":"key\n\t\t\t\t20170522171324_DDU445C48","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.3233\/JAD-2010-100543","article-title":"Mitochondria and the link between neuroinflammation and neurodegeneration","volume":"20","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"key\n\t\t\t\t20170522171324_DDU445C49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuroscience.2007.02.036","article-title":"Tumor necrosis factor-alpha induces changes in mitochondrial cellular distribution in motor neurons","volume":"146","year":"2007","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170522171324_DDU445C50","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ncb2324","article-title":"NF-\u03baB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration","volume":"13","year":"2011","journal-title":"Nat. Cell. Biol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cvr\/cvp305","article-title":"NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes","volume":"85","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"key\n\t\t\t\t20170522171324_DDU445C52","first-page":"a001271","article-title":"NF-kappaB in the nervous system","volume":"1","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C53","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB-mediated pathogenic pathways","volume":"208","year":"2011","journal-title":"J. Exp. Med."},{"key":"key\n\t\t\t\t20170522171324_DDU445C54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18388\/abp.2006_3293","article-title":"The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target","volume":"53","year":"2006","journal-title":"Acta Biochim. Pol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pneurobio.2011.10.003","article-title":"Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases","volume":"97","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C56","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","year":"2009","journal-title":"Cell Biol."},{"key":"key\n\t\t\t\t20170522171324_DDU445C57","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522171324_DDU445C58","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522171324_DDU445C59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mcn.2005.10.016","article-title":"The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS","volume":"31","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C60","doi-asserted-by":"crossref","first-page":"48572","DOI":"10.1074\/jbc.M108213200","article-title":"Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma","volume":"276","year":"2001","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522171324_DDU445C61","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1298","article-title":"17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration","volume":"11","year":"2005","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522171324_DDU445C62","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1523\/JNEUROSCI.0388-10.2010","article-title":"Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy","volume":"30","year":"2010","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C63","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1074\/jbc.275.12.8772","article-title":"Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract","volume":"275","year":"2000","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522171324_DDU445C64","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","article-title":"CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model","volume":"27","year":"2007","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522171324_DDU445C65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/ncomms2417","article-title":"Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration","volume":"4","year":"2013","journal-title":"Nat. Commun."},{"key":"key\n\t\t\t\t20170522171324_DDU445C66","first-page":"365","article-title":"Quantitative immunohistochemical determination of 8-hydroxy-2\u2032-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model","volume":"76","year":"1997","journal-title":"Lab. Invest."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T11:33:23Z","timestamp":1746358403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddu445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,8,28]]},"published-print":{"date-parts":[[2015,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddu445","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}